Advanced search
Publication Cover
Acta Oncologica Volume 45, 2006 - Issue 2
Journal homepage
1,332
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group

Marco Benasso Istituto Nazionale per la Ricerca sul Cancro, Genova, ItalyCorrespondence[email protected]
,
Anna Ponzanelli Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Marco Merlano Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy
,
Gianmuro Numico Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy
,
Isabella Ricci Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Viviana Vigo Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Francesco Grossi Policlinico Universitario, Udine, Italy
,
Dino Amadori Azienda Ospedaliera Morgagni-Pierantoni, Forlì, Italy
,
Giovanna Cavallo Ospedale Bellaria, Bologna, Italy
,
Barbara Capaccetti Bristol-Myers Squibb, Roma, Italy
,
Paola Taveggia Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
,
Luca Boni Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
&
Riccardo Rosso Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
 show all
Pages 168-174 | Received 29 Apr 2005, Published online: 08 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mitul D Gandhi & Mark Agulnik. (2014) Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib. OncoTargets and Therapy 7, pages 245-251.
Read now
Pol M Specenier & Jan B Vermorken. (2008) Recurrent head and neck cancer: current treatment and future prospects. Expert Review of Anticancer Therapy 8:3, pages 375-391.
Read now

Articles from other publishers (11)

Jin Chen, Qiulan Li & Yan Jiang. (2023) Chrysin promotes Cisplatin-induced apoptosis via oxidative DNA damage in oral squamous cell carcinoma. Biochemical Systematics and Ecology 108, pages 104623.
Crossref
Luciana Yamamoto de Almeida, Fernanda dos Santos Moreira, Guilherme Augusto Silva dos Santos, Florence Juana Maria Cuadra Zelaya, César Alexander Ortiz, Michelle Agostini, Flávia Sammartino Mariano, Débora Campanella Bastos, Ulisses Ribaldo Nicolau Daher, Luiz Paulo Kowalski, Ricardo D. Coletta & Edgard Graner. (2021) FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral Diseases 29:2, pages 649-660.
Crossref
Petr Szturz & Jan B. Vermorken. (2020) Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher. Oral Oncology 101, pages 104492.
Crossref
W. Smolka, C.‐P. Cornelius & G. Mast. (2015) Survival rates after surgical salvage procedures using mandible external pin fixation. Oral Surgery 9:1, pages 19-24.
Crossref
Petr Szturz & Jan B. Vermorken. 2016. Head and Neck Cancer. Head and Neck Cancer 711 729 .
Jihua Zheng, Jianguang Lin, Lin Wang, Juan Zhou, Bo Xie, Tianwen Xu & Weimin Zhang. (2014) Metastatic Nasopharyngeal Carcinoma Outcomes in Patients on Cisplatin with Nolatrexed or 5-Fluorouracil. Oncology Research and Treatment 37:10, pages 540-544.
Crossref
Kazuki Yamasaki, Shigetoshi Horiguchi, Motoyoshi Kurosaki, Naoki Kunii, Kaoru Nagato, Hideki Hanaoka, Naomi Shimizu, Naoyuki Ueno, Seiji Yamamoto, Masaru Taniguchi, Shinichiro Motohashi, Toshinori Nakayama & Yoshitaka Okamoto. (2011) Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clinical Immunology 138:3, pages 255-265.
Crossref
Jan B. Vermorken. 2011. Head and Neck Cancer. Head and Neck Cancer 651 664 .
Jérôme Fayette, Anthony Montella, Sylvie Chabaud, Thomas Bachelot, Pascal Pommier, Didier Girodet, Séverine Racadot, Xavier Montbarbon, Bertrand Favier & Philippe Zrounba. (2010) Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution. Anti-Cancer Drugs 21:5, pages 553-558.
Crossref
Jacques Bernier. (2009) Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neck. Oncology Reviews 3:4, pages 247-256.
Crossref
Pol M. Specenier & Jan B. Vermorken. (2009) Current concepts for the management of head and neck cancer: Chemotherapy. Oral Oncology 45:4-5, pages 409-415.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.